{{Infobox disease 
 | Name            = 2-Hydroxyglutaric aciduria 
 | Image           = Alpha-hydroxyglutaric acid.png 
 | Caption         = [[Alpha-Hydroxyglutaric acid]] 
 | DiseasesDB      = 34515 
 | DiseasesDB_mult = {{DiseasesDB2|34514}}  
 | ICD10           = 
 | ICD9            = 
 | ICDO            = 
 | OMIM            = 600721 
 | OMIM_mult       = {{OMIM2|236792}}{{OMIM2|613657}}{{OMIM2|615182}}  
 | MedlinePlus     = 
 | eMedicineSubj   = 
 | eMedicineTopic  = 
 | MeshID          = 
}}
'''2-hydroxyglutaric aciduria''' is a group of rare neurometabolic disorders characterized by the significant elevation of urinary levels of [[hydroxyglutaric acid]]. It is either [[autosomal recessive]] or [[autosomal dominant]].

==Classification==
[[Image:autorecessive.svg|thumb|right|Most forms of 2-Hydroxyglutaric aciduria have an autosomal recessive pattern of inheritance.]]

2-hydroxyglutaric aciduria is an [[organic aciduria]], and because of the stereoisomeric property of 2-hydroxyglutarate different variants of this disorder are distinguished:

===L-2-hydroxyglutaric aciduria===

The L-2 form is more common, severe, and mainly affects the [[central nervous system]]. The basal ganglia are affected, and cystic cavitations in the white matter of the [[brain]] are common, beginning in infancy. This form is chronic, with early symptoms such as [[hypotonia]], tremors, and [[epilepsy]] declining into [[spongiform]] [[leukoencephalopathy]], muscular [[choreodystonia]], [[mental retardation]], and [[psychomotor]] regression.<ref name=l2one>{{cite journal |author=Seijo-Martinez M, Navarro C, Castro del Rio M, Vila O, Puig M, Ribes A, Butron M |title=L-2-hydroxyglutaric aciduria: clinical, neuroimaging, and neuropathological findings |journal=Arch Neurol. |volume=62 |issue=4 |pages=666–670 |year=2005 |pmid=15824270 |doi=10.1001/archneur.62.4.666 }}</ref>

It is associated with [[L2HGDH]].<ref name="pmid15385440">{{cite journal |author=Topçu M, Jobard F, Halliez S, ''et al.'' |title=L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1 |journal=Hum. Mol. Genet. |volume=13 |issue=22 |pages=2803–11 |year=2004 |month=November |pmid=15385440 |doi=10.1093/hmg/ddh300 |url=http://hmg.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=15385440}}</ref>

===D-2-hydroxyglutaric aciduria===

The D2 form is rare, with symptoms including [[macrocephaly]], [[cardiomyopathy]], [[mental retardation]], [[hypotonia]], and cortical [[blindness]].<ref name=d2one>{{cite journal |author=Nyhan WL, Shelton GD, Jakobs C, Holmes B, Bowe C, Curry CJ, Vance C, Duran M, Sweetman L |title=D-2-hydroxyglutaric aciduria |journal=J Child Neurol. |volume=10 |issue=2 |pages=137–142 |year=1995 |pmid=7782605 |doi=10.1177/088307389501000216 }}</ref>

It is caused by recessive mutations in [[D2HGDH]]<ref name="pmid15609246">{{cite journal | author = Struys EA, Salomons GS, Achouri Y, Van Schaftingen E, Grosso S, Craigen WJ, Verhoeven NM, Jakobs C | title = Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria | journal = Am J Hum Genet | volume = 76 | issue = 2 | pages = 358–60 | year = 2005 | month = Jan | pmid = 15609246 | pmc = 1196381 | doi = 10.1086/427890 }}</ref> (type I) or by dominant gain-of-function mutations in [[IDH2]]<ref name="pmid20847235">{{cite journal |author=Kranendijk M, Struys EA, van Schaftingen E, ''et al.'' |title=IDH2 mutations in patients with D-2-hydroxyglutaric aciduria |journal=Science |volume=330 |issue=6002 |pages=336 |year=2010 |pmid=20847235 |doi=10.1126/science.1192632 }}</ref> (type II).

===Combined D-2- and L-2-hydroxyglutaric aciduria===

The combined form is characterized by severe early-onset epileptic [[encephalopathy]] and absence of developmental progress.<ref name="pmid10963100">{{cite journal |author=Muntau A, Röschinger W, Merkenschlager A, van der Knaap MS,''et al.'' |title=Combined D-2- and L-2-hydroxyglutaric aciduria with neonatal onset encephalopathy: a third biochemical variant of 2-hydroxyglutaric aciduria? |journal=Neuropediatrics |volume=31 |issue=3 |pages=137–40 |year=2000 |pmid=10963100 |doi=10.1055/s-2000-7497 }}</ref> It is caused by recessive mutations in ''SLC25A1'' encoding the mitochondrial citrate carrier. <ref name="pmid23561848">{{cite journal |author=Nota B, ''et al.''|title=Deficiency in SLC25A1, Encoding the Mitochondrial Citrate Carrier, Causes Combined D-2- and L-2-Hydroxyglutaric Aciduria.|journal=The American Journal of Human Genetics|volume=92|issue=4|pages=627-631|year=2013|pmid=23561848|doi=10.1016/j.ajhg.2013.03.009}}</ref>

==See also==
* [[2-hydroxyglutarate synthase]]
* [[2-hydroxyglutarate dehydrogenase]]
* [[Hydroxyacid-oxoacid transhydrogenase]]

==References==
{{reflist}}

{{Amino acid metabolic pathology}}

[[Category:Inborn errors of metabolism]]
[[Category:Autosomal recessive disorders]]
[[Category:Rare diseases]]